Evidence map›Paper›PMID 34326690›Full record

ArticleInternational journal of biological sciences2021

Cantharidin inhibits osteosarcoma proliferation and metastasis by directly targeting miR-214-3p/DKK3 axis to inactivate β-catenin nuclear translocation and LEF1 translation.

Shaopu Hu, Junli Chang, Hongfeng Ruan, Wenlan Zhi, Xiaobo Wang, Fulai Zhao, Xiaoping Ma, Xingyuan Sun, Qianqian Liang, Hao Xu and 2 more

Abstract read
In one paragraph

Article in International journal of biological sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Melittin inhibits osteosarcoma growthJournal of Cancer · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shaopu HuLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Junli ChangLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Hongfeng RuanLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Wenlan ZhiLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Xiaobo WangLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Fulai ZhaoLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Xiaoping MaLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Xingyuan SunLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Qianqian LiangLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Hao XuLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Yongjun WangLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.
Yanping YangLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

3' Untranslated RegionsAdaptor Proteins, Signal TransducingAnimalsApoptosisbeta CateninBone NeoplasmsCantharidinCarcinogenesisCell Line, TumorCell ProliferationEnzyme InhibitorsFemaleGene Expression Regulation, NeoplasticHumansLymphoid Enhancer-Binding Factor 1Mice3' Untranslated RegionsAdaptor Proteins, Signal Transducingbeta CateninCantharidinDKK3 protein, humanEnzyme InhibitorsLEF1 protein, humanLymphoid Enhancer-Binding Factor 1MicroRNAsMIRN214 microRNA, humanCantharidinDKK3miR-214-3posteosarcomaWnt/β-catenin

Identifiers

PMID34326690
PMCPMC8315017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.